Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study

Transplant International : Official Journal of the European Society for Organ Transplantation
Ella J Ariza-HerediaVictor E Mulanovich

Abstract

Acyclovir is commonly used to prevent and treat herpes simplex virus (HSV) reactivation after hematopoietic cell transplant (HCT), and only few reports have been published on acyclovir-resistant HSV in HCT recipients. We reviewed the medical records of patients with a microbiologic diagnosis of acyclovir-resistant HSV by plaque reduction test who received an HCT from 2002 through 2014. A total of 4 028 HCTs were performed during the study period, and 18 of the recipients met the diagnostic criteria for acyclovir-resistant HSV. All cases had undergone allogeneic HCTs. Most patients were in the pre-engraftment period or on systemic corticosteroid therapy for graft-versus-host disease (GVHD). The median time between diagnosis and susceptibility testing was 15 days, and antiviral therapy was changed at a median of 27 days. Patients required prolonged therapy (~80 days), and many had serious complications including renal failure and hospitalization. In conclusion, acyclovir-resistant HSV infection is more likely during the period of profound deficit in T-cell-mediated immunity and is associated with significant morbidities. Higher doses of acyclovir prophylaxis might be needed for patients with history of HSV during pre-engraftment ...Continue Reading

References

Mar 1, 1984·Annals of Internal Medicine·C V Vartian
Mar 21, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A E LoPrestiD B Mendel
Oct 3, 1998·Bone Marrow Transplantation·J M DarvilleA B Foot
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Y ChenP Ribaud
Oct 9, 2002·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Doris ChiboChristopher Birch
May 22, 2003·Dermatologic Clinics·Suneel Chilukuri, Ted Rosen
Dec 2, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Růzena StránskáAnton M van Loon
Jul 12, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Denis MalvyUNKNOWN RESSAC Study Group
Sep 16, 2008·Best Practice & Research. Clinical Haematology·Kirsten M Williams, Ronald E Gress
Apr 20, 2010·Molecular and Cellular Endocrinology·Agnes E Coutinho, Karen E Chapman
Apr 29, 2010·JAMA : the Journal of the American Medical Association·Alois GratwohlUNKNOWN Worldwide Network of Blood and Marrow Transplantation
Jul 10, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Janet H KimJanice M Y Brown
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Jocelyne Piret, Guy Boivin
Jul 23, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Yi WangTao Peng
Apr 10, 2013·Proceedings of the National Academy of Sciences of the United States of America·Adalbert KrawczykJürgen Krauss
Jul 31, 2013·Transplant Infectious Disease : an Official Journal of the Transplantation Society·K KawamuraY Kanda
Oct 25, 2013·Current Opinion in Infectious Diseases·Graciela Andrei, Robert Snoeck
Sep 11, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Keith D TardifRobert Schlaberg
Oct 27, 2016·Current Opinion in Infectious Diseases·Jocelyne Piret, Guy Boivin
Jan 1, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Farah SahooMichael Boeckh
Mar 7, 2017·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yu AkahoshiYoshinobu Kanda

❮ Previous
Next ❯

Citations

Jan 25, 2019·Blood·Stefanie SarantopoulosKeith M Sullivan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
H R NaikPranatharthi Chandrasekar
Antimicrobial Agents and Chemotherapy
L H Goldberg, J Sperber
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Janet H KimJanice M Y Brown
© 2022 Meta ULC. All rights reserved